Biome Grow (BIOIF) Stock Price, News & Analysis

Company Overview

Biome Grow Inc. (OTCMKTS: BIOIF) is a biotechnology company focused on the development, production and commercialization of microbial-based solutions for plant health and crop enhancement. The company’s proprietary platform harnesses beneficial bacteria and fungi to create soil amendments, foliar sprays and seed treatments designed to improve nutrient uptake, bolster disease resistance and support sustainable cultivation practices.

Biome Grow’s product portfolio caters primarily to high-value agricultural markets, including cannabis, horticulture and specialty crops. Its offerings are formulated to address key challenges faced by growers, such as soil depletion, pathogen pressure and inconsistent yields. Research and development activities are conducted at facilities in British Columbia, where the company also oversees manufacturing and quality control of its biological inputs.

The company serves growers across Canada and the United States, with strategic efforts underway to expand into select international markets. Biome Grow works in collaboration with academic institutions and industry partners to refine its technologies and validate product performance under commercial growing conditions. The leadership team comprises professionals with backgrounds in microbiology, agronomy and commercial operations, positioning the company to advance its mission of delivering sustainable, science-backed crop inputs.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 20,538 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BIOIF
• CIK: N/A
• Web: www.biomegrow.com
• Phone: 416-875-8395
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A